Literature DB >> 33677713

Aerosol extractor for airway management of COVID-19 patients.

Tomoyuki Saito1, Asuka Fujishiro2, Takashi Asai2.   

Abstract

Entities:  

Year:  2021        PMID: 33677713      PMCID: PMC7937356          DOI: 10.1007/s00540-021-02916-w

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
To the Editor: Airway management in patients with COVID-19 would increase the risk of spreading viral aerosol from the patient’s airway, exposing healthcare workers to virus infection [1-3]. Personal protective equipment (PPE) is recommended during airway management, but it may not fully prevent viral infection [2, 3]. A protective barrier enclosure with negative pressure may minimize the spread of aerosols [2, 3], but it may paradoxically increase the risk of infection, by damaging the PPE [2]. We have started to use a transportable compact high-flow extractor (Free-100M®, Forest-one, Tokyo, Japan), which consists of a suction port, a length-variable swing arm, and directed high flow suction (with a 12-phase power vacuum) with ultra-efficiency particulate (ULPA) filter that removes 99.99% of all airborne pathogens (ESM Fig. 1). To see the efficacy of the suction system, simulated aerosols (particle sizes: 2–4 μm) were produced using a small-volume nebulizer (Teleflex, PN; 6 ml saline at 6 l min−1) which was placed in the manikin’s mouth, and a suction port placed approximately 20 cm above of the manikin’s chest. We have found that Free-100M® effectively suctioned aerosols coming out from the mouth (ESM Fig. 1; Supplementary movie 1). As the speed of spreading droplets and aerosols during coughing would be faster than the simulated aerosols in this study, the efficacy of this air extractor needs to be assessed during coughing, but the extractor would be useful in removing aerosols coming out from the patient while not coughing. Because patients without apparent symptoms and without diagnosis of COVID-19 may also be infectious, we believe that Free-100M® may be routinely used, to minimize the risk of infection to healthcare worker during airway management in patients with and without diagnosis of COVID-19. Below is the link to the electronic supplementary material. Supplementary file1 (MPG 8996 KB) Fig. 1: High-flow extractor with (ULPA) filter for suctioning simulated viral aerosols (particle sizes: 2-4 μm) for a patient with COVID-19 (DOCX 97 KB)
  3 in total

1.  Anesthesia in the times of COVID-19.

Authors:  Michiaki Yamakage
Journal:  J Anesth       Date:  2021-06       Impact factor: 2.931

2.  Airtight, flexible, disposable barrier for extubation.

Authors:  Kayo Hirose; Kanji Uchida; Shinjiro Umezu
Journal:  J Anesth       Date:  2020-06-14       Impact factor: 2.078

Review 3.  Aerosol containment device for airway management of patients with COVID-19: a narrative review.

Authors:  Tomoyuki Saito; Takashi Asai
Journal:  J Anesth       Date:  2020-11-23       Impact factor: 2.078

  3 in total
  1 in total

1.  Double-C hold for bag-mask ventilation during resuscitation.

Authors:  Markus Isser; Hannah Salchner; Wolfgang Lederer
Journal:  J Anesth       Date:  2021-04-24       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.